- Getinge’s adjusted operating profit for Q1 reached SEK896 million, marking a 14% year-over-year increase and surpassing the estimate of SEK769 million.
- Net sales rose to SEK8.32 billion, an 11% increase from the previous year, exceeding the expected SEK8.21 billion.
- Acute Care Therapies net sales demonstrated significant growth with a 20% rise to SEK4.78 billion.
- Life Science net sales slightly declined by 1.5% to SEK950 million, below the estimated SEK1.03 billion.
- Surgical Workflows net sales saw a modest increase of 0.6% to SEK2.60 billion, which is under the estimated SEK2.69 billion.
- Organic revenue overall increased by 6.2%.
- Acute Care Therapies reported a strong 12.4% growth in organic revenue, surpassing the estimated growth of 6.65%.
- Life Science experienced a decline in organic revenue by 2.3%.
- Surgical Workflows’ organic revenue slightly decreased by 0.2%.
- Total orders for the period were SEK8.63 billion, up by 7.1% year-over-year.
- The gross margin was reported at 49.2%, higher than the estimate of 48.6%.
- Getinge forecasts organic revenue growth to remain between 2% and 5% for the year.
- Mattias Perjos, President & CEO, highlighted healthy organic sales growth and improved adjusted operating profit despite currency-related challenges.
- Getinge shares fell by 3.8% to SEK186.80 with a trading volume of 979,242 shares.
- Analyst ratings on Getinge include 8 buys, 5 holds, and 1 sell.
A look at Getinge AB Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Getinge AB, a company specializing in equipment for sterilization and disinfection, holds a promising long-term outlook based on Smartkarma Smart Scores. With a solid Value score of 4, Getinge is deemed to offer good value for investors. Additionally, the company’s Momentum score of 4 indicates strong market momentum, which could lead to positive price performance in the future. While the Growth, Resilience, and Dividend scores are slightly lower at 3, they still suggest stability and potential for growth over the long term.
Based on its business of developing, manufacturing, and selling sterilization and disinfection equipment, Getinge AB serves various sectors including pharmaceutical companies, hospitals, dental clinics, and laboratories. With production facilities in key locations like the United Kingdom, France, the United States, and Australia, the company distributes its products globally through subsidiaries, sales offices, and distributors. This diversified market presence positions Getinge AB well for sustained growth and success in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
